Atlas Trials

Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib

Clinical trial NCT00667147 · COMPLETED

Trial details

NCT number
NCT00667147
Sponsor
University of Southern California
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumors
Start date
2008-03-01
Primary completion
2012-05-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.